Cramer issues a warning on biotech stocks — there's new risk that you need to consider
December 01, 2016 at 19:03 PM EST
Jim Cramer says investors need to be careful in high-risk cancer immunotherapy stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.